These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2857129)

  • 1. Toxicity of D-galactosamine for rat hepatocytes in monolayer culture.
    Tran-Thi TA; Phillips J; Falk H; Decker K
    Exp Mol Pathol; 1985 Feb; 42(1):89-116. PubMed ID: 2857129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
    Schiessel C; Forsthove C; Keppler D
    Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-inducible cytotoxicity in liver cell cultures--I.
    Hartung T; Wendel A
    Biochem Pharmacol; 1991 Aug; 42(5):1129-35. PubMed ID: 1872897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of galactosamine cytotoxicity in an in vivo/in vitro hepatocellular toxicity model.
    MacDonald JR; Thayer KJ; White C
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):269-77. PubMed ID: 3603561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells.
    Stachlewitz RF; Seabra V; Bradford B; Bradham CA; Rusyn I; Germolec D; Thurman RG
    Hepatology; 1999 Mar; 29(3):737-45. PubMed ID: 10051475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the age-dependent effects of galactosamine in primary rat hepatocyte cultures.
    Abdul-Hussain SK; Mehendale HM
    Toxicol Appl Pharmacol; 1991 Mar; 107(3):504-13. PubMed ID: 2000637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system.
    McMillan JM; Jollow DJ
    Res Commun Mol Pathol Pharmacol; 1995 Jun; 88(3):327-38. PubMed ID: 8564388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-galactosamine induced hepatocyte apoptosis is inhibited in vivo and in cell culture by a calcium calmodulin antagonist, chlorpromazine, and a calcium channel blocker, verapamil.
    Tsutsui S; Itagaki S; Kawamura S; Harada K; Karaki H; Doi K; Yoshikawa Y
    Exp Anim; 2003 Jan; 52(1):43-52. PubMed ID: 12638236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of lactate dehydrogenase leakage from normal and D-galactosamine-treated hepatocytes in monolayer culture.
    Eisenmann A; Phillips JE; Schulze-Specking A; Decker K
    Hoppe Seylers Z Physiol Chem; 1984 Apr; 365(4):427-36. PubMed ID: 6735354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mature hepatocytes actively divide and express gamma-glutamyl transpeptidase after D-galactosamine liver injury.
    Kitten O; Ferry N
    Liver; 1998 Dec; 18(6):398-404. PubMed ID: 9869394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The model of D-galactosamine-induced injury of rat hepatocytes in primary culture.
    Kucera O; Lotková H; Kand'ár R; Hézová R; Muzáková V; Cervinková Z
    Acta Medica (Hradec Kralove); 2006; 49(1):59-65. PubMed ID: 16696445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosamine-induced sensitization to the lethal effects of endotoxin.
    Galanos C; Freudenberg MA; Reutter W
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5939-43. PubMed ID: 293694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures.
    McMillan JM; Jollow DJ
    Toxicol Appl Pharmacol; 1992 Aug; 115(2):234-40. PubMed ID: 1641857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactosamine decreases nitric oxide formation in cultured rat hepatocytes: mechanism of suppression.
    McMillan JM
    J Biochem Mol Toxicol; 1999; 13(3-4):143-8. PubMed ID: 10098899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and maintenance of monolayer hepatocytes from the livers of toxin-treated rats.
    MacDonald JR; Thayer KJ; Smuckler EA
    Exp Mol Pathol; 1987 Feb; 46(1):64-77. PubMed ID: 3803538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the hepatotoxicity of galactosamine/endotoxin or galactosamine/TNF in the perfused mouse liver.
    Wang JF; Wendel A
    Biochem Pharmacol; 1990 Jan; 39(2):267-70. PubMed ID: 2302253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine protects liver from injury caused by F-galactosamine and CCl4.
    Maezono K; Kajiwara K; Mawatari K; Shinkai A; Torii K; Maki T
    Hepatology; 1996 Jul; 24(1):185-91. PubMed ID: 8707260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
    Wendel A; Tiegs G
    Biochem Pharmacol; 1986 Jul; 35(13):2115-8. PubMed ID: 3729968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin.
    Mihas AA; Ceballos R; Mihas TA; Hirschowitz BI
    J Med; 1990; 21(6):301-11. PubMed ID: 2093097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dimethyl sulfoxide on cytosolic calcium in cultured rat hepatocytes injured by D-galactosamine.
    Liu HP; Cong Z
    Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):139-42. PubMed ID: 1317986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.